Avanos Medical
AVNS
274 hedge funds and large institutions have $1.13B invested in Avanos Medical in 2023 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 72 increasing their positions, 93 reducing their positions, and 40 closing their positions.
560% more call options, than puts
Call options by funds: $33K | Put options by funds: $5K
0.51% more ownership
Funds ownership: 94.55% → 95.07% (+0.51%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5% less funds holding
Funds holding: 287 → 274 (-13)
13% less capital invested
Capital invested by funds: $1.3B → $1.13B (-$171M)
23% less repeat investments, than reductions
Existing positions increased: 72 | Existing positions reduced: 93
30% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 40
Top Buyers
| 1 |
WHG
Westwood Holdings Group
Dallas,
Texas
|
+$18.7M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$8.51M |
| 3 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$7.12M |
| 4 |
EF
Empowered Funds
Havertown,
Pennsylvania
|
+$3.61M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$3.44M |
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$9.54M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$9.04M |
| 3 |
Envestnet Asset Management
Chicago,
Illinois
|
-$4.6M |
| 4 |
BlackRock
New York
|
-$4.23M |
| 5 |
Morgan Stanley
New York
|
-$4.21M |
AVNS Hedge Fund Activity: Q2 2023 in Review
274 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q2 2023, worth a combined $1.13B — down 13% from $1.3B a quarter earlier.
Sellers outnumbered buyers: 40 funds closed out of AVNS and 28 opened new positions — a net loss of 12 holders — while 93 trimmed existing stakes and 72 added.
The largest buyer was Westwood Holdings Group, adding an estimated $18.7M. The largest seller was Wellington Management Group, exiting entirely with an estimated $9.54M sold.
- 274 institutional investors held Avanos Medical (AVNS) as of Q2 2023, down from 287 in Q1 2023.
- Funds reported $1.13B of Avanos Medical stock for Q2 2023, down 13% quarter-over-quarter.
- 28 funds opened new Avanos Medical positions in Q2 2023 and 40 closed out, a net change of -12 holders.
- The largest Avanos Medical buyer in Q2 2023 was Westwood Holdings Group, an estimated $18.7M added.
- The largest Avanos Medical seller in Q2 2023 was Wellington Management Group, an estimated $9.54M sold.
Based on aggregated 13F filings for Q2 2023.